Boston, MA · Founded 2022 · Privately Held (backing)
Developer of bifunctional small-molecule therapeutics designed to eliminate disease-driving cells. Solu Therapeutics is based in Boston, MA and was founded in 2022. Its last reported valuation was $104 million in Apr 2025. It has raised $72 million.
Last reported valuation
$104.0M
Oct 2026
Priced at
—
Total raised
$72.0M
Last round
—
Team — not yet on record
No current team members for Solu Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Solu Therapeutics with a free account
·The complete investor list: 11 names
·Watch Solu Therapeutics: the Monday email on marks, rounds and moves
